Estimation of Reserve Albumin Equivalent Concentration for Binding of Bilirubin

  • Rolf Brodersen


Let us consider a hypothetical case, a prematurely born infant is admitted to an intensive care unit with respiratory distress and jaundice and having received treatment with a sulfonamide. On clinical grounds this infant is thought to be in danger of kernicterus. Is it possible, by studying blood chemistry, to assess the risk in quantitative terms? And can we evaluate the success of therapy, exchange transfusion and light, and tell when the risk is over on the basis of blood tests? These questions have often been asked but have never been finally answered.


Exchange Transfusion Neonatal Jaundice Neonatal Hyperbilirubinemia Pure Competition Standard Albumin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Brodersen, S. Andersen, C. Jacobsen, O. Sønderskov, F. Ebbesen, W.J. Cashore, and S. Larsen, Determination of reserve albumin-equivalent for ligand-binding, probing two distinct binding functions of the protein, Anal. Biochem. 121:395 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    W.J. Cashore, W. Oh, and R. Brodersen, Reserve albumin and bilirubin toxicity index in infant serum, Acta Pædiatr. Scand. 72:415 (1983).Google Scholar
  3. 3.
    F. Ebbesen, Effect of exchange transfusion on serum reserve albumin for binding of bilirubin and index of serum bilirubin toxicity, Acta Pædiatr. Scand. 70: 643 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    F. Ebbesen, The relationship between serum bilirubin and reserve albumin for binding of bilirubin during phototherapy of preterm infants, Acta Pædiatr. Scand. 70:405 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    F. Ebbesen, Bilirubin, reserve albumin for binding of bilirubin and pH in plasma during phototherapy (ordinary and double light) of term newborn infants, Acta Pædiatr. Scand. 70:223 (1981).PubMedCrossRefGoogle Scholar
  6. 6.
    F. Ebbesen and R. Brodersen, Albumin administration combined with phototherapy in treatment of hyperbilirubinemia in low-birth-weight infants, Acta Pædiatr. Scand. 70:649 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    F. Ebbesen and R. Brodersen, Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinemia, Acta Pædiatr. Scand. 71:85 (1982).CrossRefGoogle Scholar
  8. 8.
    W.J. Cashore, M. Funato, G. Peter, and W. Oh, Bilirubin displacement from albumin by beta-lactam antibiotics, Pediatr. Res. 16/4:122A (1982).Google Scholar
  9. 9.
    R. Brodersen and F. Ebbesen, Bilirubin displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants, J. Pharm. Sci. 72: 248 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    F. Ebbesen and R. Brodersen, Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: Consideration of blood/brain bilirubin transfer equilibrium, Early Hum. Develop. 6:341 (1982).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Rolf Brodersen
    • 1
  1. 1.Institute of Medical BiochemistryUniversity of AarhusAarhus CDenmark

Personalised recommendations